Acorda Therapeutics

FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
Xconomy
Tue, 08/29/17 - 09:32 am
FDA
Acorda Therapeutics
Parkinson's Disease
Inbrija
Bass Battled U.S. Drug Patents and Prices But Lost to ‘Cabal’
Bloomberg
Mon, 04/10/17 - 10:06 am
Kyle Bass
patents
drug pricing
AMPYRA
Acorda Therapeutics
multiple sclerosis
Acorda is shifting into survival mode. And it’s going to start by axing more than 100 staffers.
Endpoints
Wed, 04/5/17 - 12:05 pm
Acorda Therapeutics
layoffs
AMPYRA
Patent decision puts 95% of Acorda revenue at risk
BioPharma Dive
Tue, 04/4/17 - 07:23 pm
Acorda Therapeutics
patents
AMPYRA
multiple sclerosis
MS
Acorda plans NDA for inhaled Parkinson’s drug after touting long-term safety data
Mass Device
Sat, 04/1/17 - 08:03 am
Acorda Therapeutics
Parkinson's Disease
CVT-301
Levodopa
Acorda reports 4Q loss
Yahoo/AP
Tue, 02/14/17 - 12:08 pm
Acorda Therapeutics
earnings
Acorda stock surges 9% after positive late-stage clinical trial results for Parkinson's drug
Marketwatch
Thu, 02/9/17 - 10:49 am
Acorda Therapeutics
clinical trials
CVT-301
Parkinson's Disease
Trial miss derails Acorda's Ampyra plans
BioPharma Dive
Tue, 11/22/16 - 11:37 am
Acorda Therapeutics
AMPYRA
stroke
Acorda Stroke Study Fails, Dampening Revenue Growth Plans
TheStreet.com
Mon, 11/21/16 - 11:28 am
Acorda Therapeutics
AMPYRA
stroke
3 Best Biotech Stocks of the 21st Century (So Far)
Motley Fool
Sun, 11/6/16 - 12:22 pm
biotech
Acorda Therapeutics
Gilead Sciences
Celgene
Acorda reports 3Q loss
Yahoo/AP
Thu, 10/27/16 - 09:18 am
Acorda Therapeutics
earnings
Acorda misses 4Q profit forecasts
Yahoo/AP
Thu, 02/11/16 - 09:05 pm
Acorda Therapeutics
earnings
Acorda bags PhIII Parkinson's drug in $363M Biotie buyout
Fierce Biotech
Tue, 01/19/16 - 08:20 am
Acorda Therapeutics
Parkinson's Disease
BioTie Therapies
M&A
tozadenant
Biogen Who Can Acquire It And Who It Can Acquire
Bidness, ETC
Mon, 11/16/15 - 10:42 am
Biogen
M&A
Pfizer
Allergan
Roche
Merck
Acorda Therapeutics
Acorda tops Street 3Q forecasts
Yahoo/AP
Thu, 10/22/15 - 09:42 am
earnings
Acorda Therapeutics
Bass Vows to Keep Fighting U.S. Drug Patents After Setbacks
Bloomberg
Thu, 09/3/15 - 06:34 pm
Kyle Bass
patents
Biogen
Acorda Therapeutics
Biogen patent survives challenge by hedge fund manager Kyle Bass
Yahoo/Reuters
Wed, 09/2/15 - 05:14 pm
Kyle Bass
Biogen
patents
Acorda Therapeutics
Tecfidera
3 Biotech Stocks Bucking the Stock Market Crash
Motley Fool
Sat, 08/29/15 - 09:01 am
biotech
Lexicon Pharmaceuticals
La Jolla Pharmaceutical
Acorda Therapeutics
Hedge fund manager Kyle Bass loses first challenges to pharma patents
Yahoo/Reuters
Tue, 08/25/15 - 08:37 am
patents
AMPYRA
Kyle Bass
Acorda Therapeutics
MS
multiple sclerosis
Acorda beats Street 4Q forecasts
Yahoo/AP
Thu, 02/12/15 - 09:31 am
Acorda Therapeutics
earnings

Pages